{"id":"https://openalex.org/W2000456165","doi":"https://doi.org/10.1097/jto.0b013e318292c500","title":"Thymidylate Synthase Expression and Outcome of Patients Receiving Pemetrexed for Advanced Nonsquamous Non\u2013Small-Cell Lung Cancer in a Prospective Blinded Assessment Phase II Clinical Trial","display_name":"Thymidylate Synthase Expression and Outcome of Patients Receiving Pemetrexed for Advanced Nonsquamous Non\u2013Small-Cell Lung Cancer in a Prospective Blinded Assessment Phase II Clinical Trial","publication_year":2013,"publication_date":"2013-05-30","ids":{"openalex":"https://openalex.org/W2000456165","doi":"https://doi.org/10.1097/jto.0b013e318292c500","mag":"2000456165","pmid":"https://pubmed.ncbi.nlm.nih.gov/23722170"},"language":"en","primary_location":{"id":"doi:10.1097/jto.0b013e318292c500","doi":"https://doi.org/10.1097/jto.0b013e318292c500","is_oa":true,"landing_page_url":"https://doi.org/10.1097/jto.0b013e318292c500","pdf_url":"https://www.jto.org/article/S1556-0864(15)32877-X/pdf","source":{"id":"https://openalex.org/S90745127","display_name":"Journal of Thoracic Oncology","issn_l":"1556-0864","issn":["1556-0864","1556-1380"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Thoracic Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jto.org/article/S1556-0864(15)32877-X/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113804198","display_name":"Marianne C. Nicolson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]},{"id":"https://openalex.org/I2800600548","display_name":"Aberdeen Royal Infirmary","ror":"https://ror.org/02q49af68","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800600548","https://openalex.org/I4210093322"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Marianne C. Nicolson","raw_affiliation_strings":["Thoracic Oncology, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, United Kingdom. mnicolson@nhs.net","Thoracic Oncology, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, United Kingdom. mnicolson@nhs.net","institution_ids":["https://openalex.org/I195460627","https://openalex.org/I2800600548"]},{"raw_affiliation_string":"Thoracic Oncology, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, United Kingdom","institution_ids":["https://openalex.org/I195460627","https://openalex.org/I2800600548"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011181919","display_name":"Dean Anthony Fennell","orcid":"https://orcid.org/0000-0001-7373-1312","observed_orcids":["https://orcid.org/0000-0001-7373-1312"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dean A. Fennell","raw_affiliation_strings":["Thoracic Oncology, Leicester University Hospital, Leicester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology, Leicester University Hospital, Leicester, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103808805","display_name":"David Raymond Ferry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799762726","display_name":"New Cross Hospital","ror":"https://ror.org/05w3e4z48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799762726","https://openalex.org/I4210154310"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Ferry","raw_affiliation_strings":["Thoracic Oncology, New Cross Hospital, Wolverhampton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology, New Cross Hospital, Wolverhampton, United Kingdom","institution_ids":["https://openalex.org/I2799762726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033519199","display_name":"Kenneth John O'Byrne","orcid":"https://orcid.org/0000-0002-6754-5633","observed_orcids":["https://orcid.org/0000-0002-6754-5633"]},"institutions":[{"id":"https://openalex.org/I2801780664","display_name":"Maidstone Hospital","ror":"https://ror.org/047v2cv91","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I150517883","https://openalex.org/I2801780664"]},{"id":"https://openalex.org/I4210154619","display_name":"St. James's Hospital","ror":"https://ror.org/04c6bry31","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I4210154619"]}],"countries":["GB","IE"],"is_corresponding":false,"raw_author_name":"Kenneth O'Byrne","raw_affiliation_strings":["Kent Oncology Centre, Maidstone Hospital, Maidstone, United Kingdom","Thoracic Oncology, St. James Hospital, Dublin, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kent Oncology Centre, Maidstone Hospital, Maidstone, United Kingdom","institution_ids":["https://openalex.org/I2801780664"]},{"raw_affiliation_string":"Thoracic Oncology, St. James Hospital, Dublin, Ireland","institution_ids":["https://openalex.org/I4210154619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091450277","display_name":"Riyaz N.H. Shah","orcid":"https://orcid.org/0000-0003-3374-077X","observed_orcids":["https://orcid.org/0000-0003-3374-077X"]},"institutions":[{"id":"https://openalex.org/I2801780664","display_name":"Maidstone Hospital","ror":"https://ror.org/047v2cv91","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I150517883","https://openalex.org/I2801780664"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Riyaz Shah","raw_affiliation_strings":["Kent Oncology Centre, Maidstone Hospital, Maidstone, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kent Oncology Centre, Maidstone Hospital, Maidstone, United Kingdom","institution_ids":["https://openalex.org/I2801780664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036792587","display_name":"Vanessa Alice Potter","orcid":"https://orcid.org/0009-0007-7989-0112","observed_orcids":["https://orcid.org/0009-0007-7989-0112"]},"institutions":[{"id":"https://openalex.org/I1334287468","display_name":"Nottingham University Hospitals NHS Trust","ror":"https://ror.org/05y3qh794","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Vanessa Potter","raw_affiliation_strings":["Department of Oncology, Nottingham University Hospital NHS Trust, Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Nottingham University Hospital NHS Trust, Nottingham, United Kingdom","institution_ids":["https://openalex.org/I1334287468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075003980","display_name":"G. Skailes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210154214","display_name":"Royal Preston Hospital","ror":"https://ror.org/05kpx1157","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1293129422","https://openalex.org/I4210154214"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Geraldine Skailes","raw_affiliation_strings":["Thoracic Oncology, Royal Preston Hospital, Fulwood, Preston, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology, Royal Preston Hospital, Fulwood, Preston, United Kingdom","institution_ids":["https://openalex.org/I4210154214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079389438","display_name":"S. Upadhyay","orcid":"https://orcid.org/0000-0003-4116-4792","observed_orcids":["https://orcid.org/0000-0003-4116-4792"]},"institutions":[{"id":"https://openalex.org/I4210107580","display_name":"Northern Lincolnshire and Goole Hospitals NHS Foundation Trust","ror":"https://ror.org/01ep18d71","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210107580"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sunil Upadhyay","raw_affiliation_strings":["Thoracic Oncology, Northern Lincolnshire and Goole Hospitals NHS Trust, Scunthorpe, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology, Northern Lincolnshire and Goole Hospitals NHS Trust, Scunthorpe, United Kingdom","institution_ids":["https://openalex.org/I4210107580"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051884991","display_name":"Paul D. Taylor","orcid":"https://orcid.org/0000-0002-4740-4307","observed_orcids":["https://orcid.org/0000-0002-4740-4307"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Taylor","raw_affiliation_strings":["Thoracic Oncology, University Hospital of South Manchester, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology, University Hospital of South Manchester, Manchester, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Valerie Andr\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Valerie Andr\u00e9","raw_affiliation_strings":["Global Statistical Sciences, Eli Lilly and Company, Erl Wood, Windlesham-Surrey, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Statistical Sciences, Eli Lilly and Company, Erl Wood, Windlesham-Surrey, United Kingdom","institution_ids":["https://openalex.org/I4210095227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112263320","display_name":"Tuan S. Nguyen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tuan S. Nguyen","raw_affiliation_strings":["Global Statistical Sciences, Eli Lilly and Company, Indianapolis, Indianapolis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Statistical Sciences, Eli Lilly and Company, Indianapolis, Indianapolis","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083307676","display_name":"Scott P. Myrand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott P. Myrand","raw_affiliation_strings":["Global Statistical Sciences, Eli Lilly and Company, Indianapolis, Indianapolis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Statistical Sciences, Eli Lilly and Company, Indianapolis, Indianapolis","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072452238","display_name":"Carla Visseren\u2010Grul","orcid":"https://orcid.org/0000-0003-2010-1514","observed_orcids":["https://orcid.org/0000-0003-2010-1514"]},"institutions":[{"id":"https://openalex.org/I4210123112","display_name":"Eli Lilly (Netherlands)","ror":"https://ror.org/02ve0bg52","country_code":"NL","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210123112"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Carla Visseren-Grul","raw_affiliation_strings":["Thoracic Oncology, Eli Lilly and Company, Houten, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology, Eli Lilly and Company, Houten, The Netherlands","institution_ids":["https://openalex.org/I4210123112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019353672","display_name":"Mayukh Das","orcid":"https://orcid.org/0000-0002-7384-551X","observed_orcids":["https://orcid.org/0000-0002-7384-551X"]},"institutions":[{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mayukh Das","raw_affiliation_strings":["Thoracic Oncology, Eli Lilly and Company, Basingstoke, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology, Eli Lilly and Company, Basingstoke, United Kingdom","institution_ids":["https://openalex.org/I4210095227"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112196726","display_name":"Keith M. Kerr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]},{"id":"https://openalex.org/I2800600548","display_name":"Aberdeen Royal Infirmary","ror":"https://ror.org/02q49af68","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800600548","https://openalex.org/I4210093322"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Keith M. Kerr","raw_affiliation_strings":["Thoracic Oncology, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, United Kingdom","institution_ids":["https://openalex.org/I195460627","https://openalex.org/I2800600548"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5113804198"],"corresponding_institution_ids":["https://openalex.org/I195460627","https://openalex.org/I2800600548"],"apc_list":{"value":4100,"currency":"USD","value_usd":4100},"apc_paid":null,"fwci":6.4405,"has_fulltext":true,"cited_by_count":59,"citation_normalized_percentile":{"value":0.97019926,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"8","issue":"7","first_page":"930","last_page":"939"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.7782999873161316,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.7782999873161316,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.12880000472068787,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.06369999796152115,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thymidylate-synthase","display_name":"thymidylate synthase","score":0.9660000205039978},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.9729999899864197},{"id":"https://openalex.org/keywords/non-squamous-non-small-cell-lung-cancer","display_name":"non-squamous non-small cell lung cancer","score":0.968999981880188},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.7160000205039978},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6990000009536743},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.625},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/maintenance-chemotherapy","display_name":"maintenance chemotherapy","score":0.6060000061988831},{"id":"https://openalex.org/keywords/nuclear-protein-expression","display_name":"nuclear protein expression","score":0.49300000071525574},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7250000238418579},{"id":"https://openalex.org/keywords/h-score","display_name":"H-score","score":0.4059999883174896},{"id":"https://openalex.org/keywords/gene-expression","display_name":"gene expression","score":0.37700000405311584},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.5450000166893005},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.5049999952316284},{"id":"https://openalex.org/keywords/prognostic-biomarker-validation","display_name":"prognostic biomarker validation","score":0.37599998712539673}],"concepts":[{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.9510126113891602},{"id":"https://openalex.org/C123321153","wikidata":"https://www.wikidata.org/wiki/Q22676802","display_name":"Thymidylate synthase","level":4,"score":0.9255683422088623},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8418510556221008},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.7379676103591919},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7054393291473389},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6806566119194031},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5922232866287231},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5625128149986267},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.49897027015686035},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4699096083641052},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.46257808804512024},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.43225717544555664},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4116024971008301},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.40208783745765686},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.14093202352523804},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.08356887102127075}],"mesh":[{"descriptor_ui":"D000068437","descriptor_name":"Pemetrexed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005971","descriptor_name":"Glutamates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007124","descriptor_name":"Immunoenzyme Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D013940","descriptor_name":"Thymidylate Synthase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D013940","descriptor_name":"Thymidylate Synthase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060888","descriptor_name":"Real-Time Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/jto.0b013e318292c500","doi":"https://doi.org/10.1097/jto.0b013e318292c500","is_oa":true,"landing_page_url":"https://doi.org/10.1097/jto.0b013e318292c500","pdf_url":"https://www.jto.org/article/S1556-0864(15)32877-X/pdf","source":{"id":"https://openalex.org/S90745127","display_name":"Journal of Thoracic Oncology","issn_l":"1556-0864","issn":["1556-0864","1556-1380"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Thoracic Oncology","raw_type":"journal-article"},{"id":"pmid:23722170","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23722170","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":{"id":"doi:10.1097/jto.0b013e318292c500","doi":"https://doi.org/10.1097/jto.0b013e318292c500","is_oa":true,"landing_page_url":"https://doi.org/10.1097/jto.0b013e318292c500","pdf_url":"https://www.jto.org/article/S1556-0864(15)32877-X/pdf","source":{"id":"https://openalex.org/S90745127","display_name":"Journal of Thoracic Oncology","issn_l":"1556-0864","issn":["1556-0864","1556-1380"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Thoracic Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9789000153541565}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2000456165.pdf","grobid_xml":"https://content.openalex.org/works/W2000456165.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1573184761","https://openalex.org/W1978018057","https://openalex.org/W1979300931","https://openalex.org/W1985329793","https://openalex.org/W2005244154","https://openalex.org/W2030579631","https://openalex.org/W2057955518","https://openalex.org/W2060774265","https://openalex.org/W2066059360","https://openalex.org/W2074404352","https://openalex.org/W2075421907","https://openalex.org/W2077656555","https://openalex.org/W2080911350","https://openalex.org/W2083702866","https://openalex.org/W2086003983","https://openalex.org/W2099725888","https://openalex.org/W2105464202","https://openalex.org/W2112621029","https://openalex.org/W2119366998","https://openalex.org/W2139248078","https://openalex.org/W2160571019","https://openalex.org/W2163351155","https://openalex.org/W2165691695","https://openalex.org/W2287372748","https://openalex.org/W2376139257","https://openalex.org/W2401000377","https://openalex.org/W3010883868","https://openalex.org/W3020882730","https://openalex.org/W3041047318","https://openalex.org/W4242228923","https://openalex.org/W6634228383"],"related_works":["https://openalex.org/W2589323908","https://openalex.org/W2369560177","https://openalex.org/W2136403887","https://openalex.org/W2599759402","https://openalex.org/W2556672652","https://openalex.org/W2003315615","https://openalex.org/W2047986057","https://openalex.org/W2151299797","https://openalex.org/W2011724702","https://openalex.org/W2061642719"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":6}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}